Social support and memory in postmenopausal women: a careful null
A secondary analysis of the ELITE hormone-therapy trial found hints that social ties tracked with cognition, but none survived correction for multiple testing.
For how we live.
A secondary analysis of the ELITE hormone-therapy trial found hints that social ties tracked with cognition, but none survived correction for multiple testing.
Two small pilot studies in 18-to-25-year-olds found morning bright light on its own shifted circadian timing little, while adding a timed schedule and evening blue-blockers advanced it about 35 minutes.
Applied to 411,000 UK Biobank adults, the Edmonton staging system and the Lancet Commission's clinical-obesity model classified severe disease alike but diverged on who counts as early-stage.
A network meta-analysis of 163 trials found EPA, vitamin D and a St John's wort extract beat placebo by margins so large the researchers treat them as a warning about the evidence, not a green light.
Cochrane reviews rate anti-inflammatory painkillers a very effective treatment for menstrual cramps, roughly doubling the odds of good pain relief. Exercise helps too, but on lower-quality evidence.
Trials put the pregnancy rate after emergency contraceptive pills at roughly 1-3%. But the risk rose more than threefold in obese women, and the levonorgestrel pill fared worst of all.
Cochrane's 2024 review found low-certainty evidence of a small effect since fluoride toothpaste became widespread. The IQ meta-analysis that reopened the argument reported a null below 1.5 mg/L in one key analysis.
The human intestinal-permeability literature lists endurance exercise, NSAIDs, pregnancy and surfactants as stressors. Coffee is not on that list, and alcohol's case is largely inferred.
US guidelines recommend routine chlamydia and gonorrhea screening for sexually active women under 25 and older women at higher risk. Self-collected swabs match clinician-collected ones closely.
Twelve studies in 1,158 IBS patients found gut-directed hypnotherapy improved symptoms, with the firmest results in high-volume and group delivery. The microbiome route is weaker.
A Cochrane review found women doing pelvic floor muscle training were eight times more likely to report their stress incontinence cured than untreated women — with the strongest evidence for that one condition.
A review in Gut says no intestinal disease can be cured by normalising barrier function, and that it is unproven whether restoring the barrier improves any clinical outcome at all.
A Copenhagen team has just published the protocol for the first study designed to test whether reducing PFAS exposure changes anything. That it is still a protocol tells you where the evidence stands.
A Cochrane review of 50 trials found cranberry products lower UTI risk in women with recurrent infections and in children, but no benefit in the elderly, in pregnancy, or in bladder-emptying problems.
A joint AGA and ACG guideline graded ten treatments for chronic constipation. The cheap osmotic laxative and the newest secretagogues sit in the same recommendation tier.
Hormones, surgery and painkillers can reduce pain and improve fertility, but none reliably alter the disease itself — and even removing the uterus does not guarantee the disease goes with it.
Observational studies had linked proton pump inhibitors to fractures, dementia, kidney disease and more. A randomised trial collected all of those outcomes and found only enteric infections.
The 2023 global guideline puts lifestyle first for everyone, letrozole first for fertility, and the pill for cycles and excess hair — while rating much of its own evidence low to moderate quality.
An umbrella review graded 249 effect sizes across 67 risk factors for male infertility. More than half were rated very low certainty — and the review contradicts its own table on one of them.
It found rising microbiome diversity and falling inflammatory markers in the fermented-food arm — and no change in its own primary outcome in the high-fibre arm it was compared against.
In two large clinics, the live birth rate per woman who returned to use her eggs was around 39-50% under 35 or 38, but far lower for older women — and most women who froze never came back to use them.
In modern couples timing intercourse, an estimated 18% of women aged 35-39 failed to conceive within a year — not one in three. The most alarming figures come from models, not from watching real couples try.
A 2026 meta-analysis of nine in vitro studies found a small, outlier-sensitive reduction in enamel microhardness. Every study was done on extracted teeth. The better-evidenced problem is sensitivity.
Two randomised trials in more than 1,800 children found no benefit in acute gastroenteritis. A Cochrane review of 23 trials found fewer upper respiratory infections, on low-certainty evidence.
US government metrologists sent one homogenised faecal standard to seven consumer testing services. Species counts came back ranging from 20 to 1,701 for the same material.
In a 22,785-user study of one temperature-based app, typical use failed 6.9 per 100 woman-years and perfect use 1.0 — but the study came from the maker, and traditional methods vary widely.
A systematic review in Cell called that rate implausible and said it overstates the gut microbiome's role in human disease. A separate audit found the statistical tools themselves disagree.
A million-woman Danish cohort found a modest rise in antidepressant use among hormonal contraceptive users. A Cochrane review of weight found no evidence the pill causes weight gain.
A network meta-analysis of 13 randomised trials put the diet ahead of every alternative for IBS symptoms. Its authors note the trials skipped reintroduction and personalisation entirely.
A network meta-analysis found six treatments clearing the clinically important threshold in the short term. It also graded 98.6% of the evidence very low certainty, and found nothing that held up past a year.
Two Cochrane reviews found low- to very low-certainty evidence that floss slightly reduces gum inflammation. Neither found a single trial measuring interproximal decay, the thing flossing is sold to prevent.
The numbers most methods advertise are perfect-use figures from clinical trials. In everyday use the pill fails about seven users in 100 a year, the condom about 13, withdrawal about 20.